Zhongyuan Company presented the banner to Beijing Entry-Exit Inspection and Quarantine Bureau
On March 28, 2018, Yao Tongli, Vice President of China Pharmaceutical Enterprise Development Promotion Association (hereinafter referred to as “Promotion Association”), together with Zhu Xiaoyong, President of Zhongyuan Company, and Li Zhigang, Vice President, went to Beijing Entry-Exit Inspection and Quarantine Bureau (hereinafter referred to as “Beijing Country” The inspection bureau") The Health Supervision Office presented the banner, thanking him for his strong support for China's biomedical industry and the continuous innovation of supervision services. Shao Bai, deputy director of the Beijing State Inspection Bureau, and Huang Jianhua, director of the Health Department, expressed their gratitude and cordial talks on behalf of the Beijing National Inspection Bureau.
Deputy Director Shao introduced some innovative supervision modes of the Beijing State Inspection Bureau for the entry and exit of special items in recent years. At the same time, it introduced in detail the import approval and follow-up supervision of special items such as strains, strains and standards in China by the Health Inspection Office of the Beijing State Inspection Bureau. Waiting for work. The leaders of the Beijing State Inspection Bureau are very supportive of the development of China's bio-industry, constantly innovating supervision services, and have organized a series of work such as expert evaluation and source risk assessment for products such as ATCC cells, and solved the biosafety and risk control of products in the entry and exit. Difficulties, implement effective bio-safety management for the import of high-risk products, wholeheartedly serve the majority of scientific research and enterprise users, and provide fast customs clearance services for the entry and exit of China's bio-pharmaceutical industry products.
Vice President Yao introduced the promotion meeting. The promotion meeting was established by the Ministry of Civil Affairs of the People's Republic of China and organized by the State-owned Assets Supervision and Administration Commission of the State Council as a national, professional and non-profit national first-level trade association. As a member of the Promotion Association, Zhongyuan Company is the largest foreign trade service platform for life science products in China. It has always supported the approval and supervision of biological import and export, and cooperated with national policies to operate legal compliance.
As a source company providing services for biomedical entry and exit, Zhongyuan Company has been adhering to the mission of “promoting life sciences and serving the health of all mankind” since its establishment in 2000. It has been committed to serving the Chinese biomedical industry as a Chinese organism. Drug development, biopharmaceuticals, and life sciences provide a wide range of products and services. Through this discussion, the leaders of the Beijing State Inspection Bureau have a deeper understanding of the development trend of China's bio-industry, and also affirmed the standardized operation and good service of Zhongyuan Company in the entry and exit of special items. Zhu Xiaoyong, president of Zhongyuan Company, said that the company will continue to actively cooperate with the state's safety measures and risk control in biological import and export, and together with the Beijing State Inspection Bureau to promote the healthy development of China's biomedical industry.